|Bid||0.0000 x 4000|
|Ask||0.0000 x 4000|
|Day's range||1.2800 - 1.3400|
|52-week range||0.9900 - 2.2300|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Regeneron (REGN) announces positive data on a phase III study on cholesterol treatment Evkeeza.
Novartis (NVS) Cosentyx gets a positive CHMP recommendation for the indication of juvenile idiopathic arthritis.
Endo (ENDP) plunges on reports of negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion of debt.